NASDAQ NMS - GLOBAL MARKET · OLMA
-2.24% · -$0.2200 · Vol 1.1M
Market closed · last close 4:00 PM ET · price as of 18:28:32 ET
Olema Pharmaceuticals Inc

Olema Pharmaceuticals Inc

Biotechnology
$9.60
Card
Relationship Map

Follow $OLMA

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $OLMA by email

Veridion Score

BETALOW CONF · 6 of 6 factors measuredMethodology
OLMA
Olema Pharmaceuticals Inc
Mon Sep 21 · market closed · Markets closed · resumes Tue 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
Middle range · LOW confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6 of 6 factors measured · Mon Sep 21 · market closed · Markets closed · resumes Tue 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is OLMA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading OLMA catalysts
About Olema Pharmaceuticals Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2020
Employees
150
Country
US

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$9.95
Day high
$10.13
Day low
$9.61
Previous close
$9.82
52W high
$35.83
-73.21% from high
52W low
$7.77
7% of range
Market cap
$859.2M
EPS
$-2.1300
Beta
0.98
Shares out
87.5M
Volume
1.1M
0.97× rel vol
Avg volume
1.1M
VWAP
$9.75
Price history computed in-house
1W
-1.84%
1M
-10.20%
3M
-13.82%
1Y
+15.25%
YTD
-61.60%
SMA 50 $10.97 · below
SMA 200 $17.01 · below
52W position 7%

OLMA overview

Veridion Score
59
Registered · 2026-09-21
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around OLMA.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading OLMA Form 4 filings
Public disclosures

Congress activity in OLMA

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for OLMA in the cached public ledger.

Federal contracts

OLMA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for OLMA in this window.
Lobbying spend

OLMA lobbying filings, year to date.

Registered lobbying filings matched to Olema Pharmaceuticals Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for OLMA in this window.
Loading news for OLMA
Analyst ratings
Sovereign unlock shows live analyst consensus for OLMA.
Options
Sovereign unlock shows live options positioning for OLMA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.